Acera’s mission is to set a new standard of excellence in healthcare. We take seriously the trust placed in us by patients and clinicians alike. Our team of pioneers, change agents, innovators, and scientists are bound together by an unrelenting drive to create solutions that make patients’ lives better through the development of revolutionary products that enable healing and enhance quality of life.

A Message to our Customers and Stakeholders:

Acera Surgical takes the health and well-being of our employees, as well as the patients and customers we serve, very seriously. During this COVID-19 crisis, we have taken the necessary safety measures established by the CDC to help protect our employees and their families. At the same time, we remain committed to meeting the needs of our customers and patients.

Our lead product, Restrata, is indicated for use in the management of wounds, including surgical and trauma wounds, along with pressure, diabetic, venous, and chronic vascular ulcers1. Other solutions for soft-tissue repair present tradeoffs, either for patients or providers. Autografts require a second procedure to harvest skin from a patient, leading to increased OR time and patient discomfort; many allografts require tissue tracking and special storage requirements; while most xenografts include biologic components derived from animal tissue that could present a risk of disease transmission to the patient2.

How we can help:

We manufacture our non-biologic, fully synthetic products in the U.S.A.
Unlike human or animal based tissue products, Restrata eliminates the risk of disease transmission associated with harvested tissues2
Restrata is terminally sterilized with a two-year shelf-life, and does not require any special tissue tracking or storage requirements
We have a strong supply-chain and sufficient inventory on hand to help providers and patients

Acera Surgical Inc. services

Soft-Tissue Repair Services